에 대한 최신 뉴스 Ambev (NYSE:ABEV) 주식

Ambev

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

Starbucks

Long Ideas

Trading Ideas

ABEV

GILD

SBUX

자본시장 투자자들은 종종 진입점, 숨은 보석, 가치 투자를 찾는다. 52주 최저 가격 또는 그 주변에서 거래되는 품질 주식은 이러한 기회를 제공한다.최근 52주 최저가를 경신했던 기업들을 살펴보았다. 우리는 이 중 3 개 주식은 350억 달러 시가총액으로 독자들의 주목을 끌었다. 이들은 스타벅스 (NASDAQ:SBUX), 길리어드 사이언스 (NASDAQ:GILD) 그리고 암베브 SA (NYSE:ABEV)이다.

스타벅스, 길리어드 사이언스, 암베브는 52주 최저가에: 저점에 매수해야 하나?

Ambev S.A. American Depositary Shares (Each representing 1 Common Share)

Ambev SA

As of March 7, 2025, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Weis Markets Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMK#NYSE">WMK</a>)</h3>
<ul>
<li>On Feb. 25, Weis Markets reported quarterly earnings of $1.29 per share, up from 76 cents per share from the same period last year. &#8220;Our fiscal year 2024 and fourth quarter results were in line with our expectations thanks to the efforts of our associates at every level of our company. During the year, they helped us work through inflation and supply chain issues in key segments of our business while driving sales and net income increases,&#8221; said Weis Markets, Inc. Chairman, President and CEO Jonathan H. Weis. The company's stock gained around 11% over the past month and has a <a href="https://www.benzinga.com/quote/WMK">52-week high of $77.83</a>.</li>
<li>RSI Value: 77.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>WMK Price Action: Shares of Weis Markets gained 3.4% to close at $77.26 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Anheuser-Busch Inbev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>)</h3>
<ul>
<li>On Feb. 26, Anheuser-Busch InBev reported better-than-expected fourth-quarter earnings and revenues. Beer is a passion point for consumers and a vibrant category globally. The strength of our 2024 results is a testament to the consistent execution of our strategy and the hard work and dedication of our people. We delivered EBITDA growth at the top-end of our outlook and a step change in our free cash flow generation. We are investing for the long-term and are confident in our ability to lead and grow the category.&#8221; – Michel Doukeris, CEO, AB InBev. The company's stock gained around 24% over the past month and <a href="https://www.benzinga.com/quote/BUD">has a 52-week high</a> of $67.49.</li>
<li>RSI Value: 89.9</li>
<li>BUD Price Action: Shares of Anheuser-Busch Inbev gained 0.3% to close at $62.44 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Ambev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>)</h3>
<ul>
<li>On Feb. 26, Ambev posted fourth-quarter net revenue of R$27,035 million, up 35.2% year over year The company's stock gained around 20% over the past month and has a <a href="https://www.benzinga.com/quote/ABEV">52-week high </a>of $2.58.</li>
<li>RSI Value: 77.4</li>
<li>ABEV Price Action: Shares of Ambev gained 0.9% to close at $2.21 on Thursday. </li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44083539/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Top 3 Risk Off Stocks That May Plunge In Q1

Guidance

Ambev Sees 2025 Brazil Beer Cash COGS/HL Up 5.5%-8.5%; Expects To Face More Input Cost Pressure Than In 2024, Says Aluminum Hedged Prices Are Also A Headwind

Earnings

Ambev Q4 Net Revenue R$27,035M, Up 35.2% YoY; EPS R$0.31, Up From R$0.29 YoY

AAOI

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

Several academic studies have recently examined buying undervalued stocks using tools like the Piotroski F-Score, Joel Greenblatt&#8217;s Magic Formula, and profitability factors. I have written about these studies in this column and in my weekly e-letter.
Rather than bore you with all the detailed and academic citations; I can summarize the results very quickly for you. Buying stocks that trade at low multiples of asset value and cash flows outperforms the market indexes. This approach can be very volatile. Most of the return comes from less than half of the number of stocks. There is a high failure rate for the companies that pass the initial value screens. Adding financial and quality filters to the list of cheap stocks based on earnings and asset multiples dramatically increases the return and margin of safety in value strategies.
Today, I decided to look at stocks that passed all the filters. I screened for companies that passed the Magic Formula Filters of high earning yields and high returns of capital. Then, I filtered out those with low profitability levels and Piotroski F-scores.
This produced a list of profitable companies with strong finances that are currently undervalued. I immediately noticed that the best bargains were outside the United States. This is unsurprising, given the huge performance gap over the past several years.
While running the numbers, I made a surprise discovery.
&nbsp;Buying high-quality, undervalued U.S. companies has beaten the markets even during the past five tech-dominated years.
&nbsp;Companies outside the U.S. (excluding China) have done even better.
&nbsp;Given that there are far more bargain opportunities outside the United States than inside, there is a good chance that this outperformance will continue.
Ambev SA (Ticker: ABEV) is a Brazilian brewer and distributor of popular beers like Budweiser, Corona, Stella, and others in Brazil, the Caribbean, and Central America. It also sells Pepsi (Ticker: PEP) products in the same markets.
The stock has been volatile due to turmoil in the Brazilian economy and currency fluctuations over the last year. After declining steadily over the past few years, the stock is now trading at low multiples of the business&#8217;s cash flow. T
he business generates high operating profits, and the financial statements show a healthy company with the potential for continued improvements.
The parent company, Anheuser-Busch InBev SA, owns more than 60% of the company, so there is little question about Ambev SA&#8217;s staying power.
América Móvil, S.A.B. de C.V. (Ticker: AMX) is a leading telecommunications company based in Mexico. It offers a wide range of services, including wireless voice, wireless data, and value-added services, across multiple countries.
&nbsp;After a headline-driven rough year, this company is now a compelling opportunity that no one on Wall Street is even thinking about right now. The company has demonstrated resilience in its financial performance, with service revenue growing quickly despite currency fluctuations. Its continued expansion in Latin America and Europe and rising postpaid subscriber growth enhance long-term revenue visibility.
&nbsp;Additionally, América Móvil benefits from its dominant market share in Mexico and other key regions, allowing it to generate stable cash flows.
The balance sheet is strong, and the majority owner, Mexican billionaire Carlos Slim, has deep pockets. At the current single-digit multiple of the business&#8217;s cash production.
&nbsp;América Móvil is an excellent buy for patient, aggressive investors.
Vista Energy (Ticker: VIST), the Mexican oil and gas company, is another compelling opportunity. Vista is an independent oil and gas company headquartered in Mexico City, Mexico. Established in 2017, the company focuses on the exploration and production of oil and gas, with primary operations in Argentina and Mexico.
&nbsp;Vista&#8217;s principal assets are in the Vaca Muerta formation within Argentina&#8217;s Neuquina basin. These assets make the stock a screaming buy for value-oriented investors willing to look outside the United States.
According to the few Wall Street analysts who follow the stock, it is a strong buy due to its exceptional growth potential, efficient operations, and strategic positioning in Argentina&#8217;s Vaca Muerta shale play, one of the most promising unconventional oil and gas basins outside North America.
Citigroup was just out last week with an updated buy ranking and price target that is well above the current price.
The company is profitable, in solid financial condition, and trades at bargain basement prices.
Latin America is way off Wall Street and the financial media&#8217;s radar screens. The instant experts of the internet have not yet surrendered their status as fiscal policy experts and nuclear engineers, and they are unlikely to discover that Latin countries have actual stock exchanges and economies involving more than all-inclusive resorts. These companies pass all the quality and financial strength filters and are undervalued. Owning a portfolio of overlooked international companies that pass all the filters has been a winning strategy, and I expect that to continue.

Opinion

VIST

Under the Radar: Strategic Financial Screening Reveals International Opportunity

Barclays analyst Benjamin Theurer maintains Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) with a Equal-Weight and lowers the price target from $2.5 to $2.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Ambev, Lowers Price Target to $2

WIIM

AZUL

BBDO

BSBR

Embraer-Empresa Brasileira De Aeronautica

ITUB

Companhia De Saneamento Basico Do Estado De Sao

VALE

Shares of Brazilian companies are trading lower. A new government fiscal spending package and last week's central bank rate hike could be eroding global investor confidence and raising concerns over the nation's deficit.

MELI

Shares of Brazilian stocks are trading lower amid a rise in borrowing costs and a depreciation of the Brazilian Real.

Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) shares<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> are trading lower on Thursday.</a>
The company <a target="_blank" href="https://api.mziq.com/mzfilemanager/v2/d/c8182463-4b7e-408c-9d0f-42797662435e/9d220ab4-acad-1bc2-6ca3-30487b33d05a?origin=1" rel="noreferrer noopener">reported </a>third quarter earnings per share of 4 cents, in line with the street view. Quarterly sales of $3.983 billion missed the analyst consensus estimate of $4.082 billion.
Consolidated volumes declined by 0.6%, but when excluding Argentina, there was a growth of 1.3%.
In Brazil, volumes increased by 1.3%, with beer sales growing by 0.6% and non-alcoholic beverages (NAB) rising by 3.4%. In Brazil&#8217;s beer segment, premium and super premium brands saw volume growth in the low twenties, driven by Corona, Spaten, and Original. Core plus brands grew by low teens, with the Budweiser family leading the way, while core brands Brahma and Antarctica each recorded high single-digit increases in volume.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41658099/cheez-it-parent-kellanovas-q3-earnings-organic-sales-climb-mars-buyout-vote-nears-more" rel="noreferrer noopener">Cheez It Parent Kellanova&#8217;s Q3 Earnings: Organic Sales Climb, Mars Buyout Vote Nears &amp; More</a>
In Central America and the Caribbean (CAC), volumes decreased by 0.5%, although the Dominican Republic saw a midsingle-digit increase. Additionally, soft industry conditions in Argentina and Canada contributed to volume declines of 7.7% in Latin America South (LAS) and 1.4% in Canada.
In the quarter under review, the company&#8217;s cash cost of goods sold (COGS) increased in low-single digits, primarily due to inflation and diminished benefits from commodity price hedges, while cash selling, general, and administrative expenses (SG&amp;A) rose in mid-single digits because of increased investments in brand support and higher administrative costs linked to elevated variable compensation accruals.
&#8220;Looking ahead, we remain focused on executing our commercial strategy and are confident in our preparedness for the Summer season in South America, with healthier brands and sustained all-time-high NPS levels,&#8221; Ambev said.
Price Action: ABEV shares are trading lower by 3.08% to $2.20 at last check Thursday.
Photo: Engin Akyurt from Pixabay
Also Read:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41653721/est-e-lauder-q1-earnings-china-uncertainty-hits-beauty-giant-withdraws-fy25-outlook-stock-tanks" target="_blank" rel="noreferrer noopener">Estée Lauder Q1 Earnings: China Uncertainty Hits Beauty Giant, Withdraws FY25 Outlook, Stock Tanks</a></li>
</ul>

Equities

Movers

General

Ambev Q3 Sales Miss Expectations As Volume Growth Stalls; Shares Dip

Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) reported quarterly earnings of $0.04 per share which met the analyst consensus estimate. The company reported quarterly sales of $3.983 billion which missed the analyst consensus estimate of $4.082 billion by 2.43 percent. This is a 4.30 percent decrease over sales of $4.162 billion the same period last year.

Earnings Misses

Ambev Q3 2024 GAAP EPS $0.04, Inline, Sales $3.983B Miss $4.082B Estimate

Ambev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) is inching <a href="https://www.benzinga.com/topic/golden-cross">towards a golden cross</a>—a technical signal that could suggest brighter days ahead for the stock.
As one of the largest beverage giants, Ambev has been a key player in Latin America&#8217;s beer market, dominating countries like Brazil, Argentina, and the Dominican Republic. 
But, after a challenging year with stock price declines and currency woes, could this golden cross be the turning point?
<h2 class="wp-block-heading">Ambev's Brewing Success In Latin America</h2>
Ambev isn't just any beer company. With control over <a href="https://www.moneymag.com.au/why-you-should-buy-ambev-shares-october-2024">66%</a> of Brazil&#8217;s beer market, a near-monopoly in the Dominican Republic, and substantial stakes in Argentina and Canada, this giant knows how to dominate. The company, a key part of AB InBev, has a knack for using its scale to drive profits, with a strategic focus on premium brands. 
This shift towards premium beers, coupled with steady price increases, helped Ambev weather market turbulence.
After a slowdown in 2023, Ambev is rebounding in 2024. Growth picked up in the second quarter, and with stabilizing commodity prices, the company is poised to improve margins by 2027. With an expected expansion of operating margins and continued pricing power, Ambev is looking to shake off the recent slump.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41512422/top-3-tech-stocks-youll-regret-missing-in-q4">Top 3 Tech Stocks You&#8217;ll Regret Missing In Q4</a>
<h2 class="wp-block-heading">Golden Cross On Tap: Is ABEV Ready To Shine?</h2>
For technical traders, a golden cross is a big deal—it happens when the 50-day moving average crosses above the 200-day moving average, signaling potential bullish momentum. Ambev's stock is close to making this move, and while its recent price action has been bearish, this could shift the tide.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="628" height="455" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24072132/Screenshot-2024-10-24-at-4.01.59-PM.png" alt="" class="wp-image-611723" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24072132/Screenshot-2024-10-24-at-4.01.59-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24072132/Screenshot-2024-10-24-at-4.01.59-PM-300x217.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Currently trading at $2.25, ABEV stock is still below key moving averages, signaling a bearish signal for cautious traders. ABEV stock's eight-day simple moving average stands at $2.29, while the 50-day SMA is $2.35. 
However, with a Relative Strength Index (RSI) of 38.41 and declining, Ambev stock could soon be oversold. This is when we could see some buying pressure starting to emerge. The negative 0.02 of the Moving Average Convergence/Divergence (MACD) indicator also suggests it's time to take a closer look.
<h2 class="wp-block-heading">Why Ambev&#8217;s Valuation Matters Now</h2>
Despite the technical picture, Ambev's fundamentals remain strong. Trading at a discount to historical averages, the stock offers upside potential for both price appreciation and income, with a <a href="https://www.benzinga.com/quote/ABEV/dividends">dividend yield of 6.71%</a>. The company's ability to generate strong cash flows and impressive balance sheet, including a net cash position of 10.7 billion reals (approx. $1.88 billion), make it an attractive option for long-term investors.
With third-quarter earnings approaching, now could be the time to watch Ambev stock closely. A positive earnings surprise might be the catalyst to push the stock through the golden cross threshold and into bullish territory.
Ambev's golden cross is almost here, and for savvy traders, this could mark a buying opportunity. 
While the stock has been down in 2024, its dominance in Latin America, coupled with a strong balance sheet and recovering margins, positions it well for a turnaround.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41513495/brics-summit-2024-russian-president-calls-for-de-dollarization-heres-how-it-could-impact-us-investor">BRICS Summit 2024: Russian President Calls For De-Dollarization, Here&#8217;s How It Could Impact US Investors</a></li>
</ul>
Photo: Shutterstock

Latin America

Technicals

Signals

Is A Golden Cross Brewing For Ambev? Technical Charts Show Bullish Potential

Ambev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) shares are trading higher by 0.97% to $2.08 Thursday morning after the company reported better-than-expected second-quarter <a href="https://www.benzinga.com/quote/ABEV/earnings">sales results</a>.
<h2 class="wp-block-heading">What Happened?</h2>
Ambev reported quarterly earnings of&nbsp;3 cents&nbsp;per share which met the analyst consensus estimate. The company reported quarterly sales of&nbsp;$3.847 billion&nbsp;which beat the analyst consensus estimate of&nbsp;$3.609 billion&nbsp;by&nbsp;6.6%. This figure represents a&nbsp;0.76%&nbsp;increase over sales of&nbsp;$3.818 billion&nbsp;in the same period last year.
Ambev&#8217;s CEO, Jean Jereissati, highlighted double-digit growth in Normalized EBITDA and margin expansion driven by commercial momentum and operational leverage. Total volumes showed a slight increase of 0.4% year-over-year (YoY), with net revenue rising by 4.8% YoY.
Read Also: <a href="https://www.benzinga.com/news/24/08/40101256/why-ocugen-ocgn-stock-is-falling">Why Ocugen (OCGN) Stock Is Falling</a>
The growth was primarily led by Brazil, which saw a 4.1% increase in volumes, including a 7.7% rise in non-alcoholic beverages (NAB) and a 2.9% increase in beer. Central America and the Caribbean (CAC) also experienced a 3.4% volume increase. However, volumes declined in Latin America South (LAS) by 13.7% and in Canada by 6.9%.
Net revenue per hectoliter (NR/hl) grew by 4.5%, contributing to overall net revenue increases in most business units: Brazil NAB rose by 15.0%, CAC by 8.4%, Brazil Beer by 6.9% and LAS by 0.5%, while Canada saw a 5.7% decline due to volume decreases. 
Normalized EBITDA meanwhile increased by 15.9% YoY, driven by strong performance in Brazil (23.5% growth), CAC (17.9%), and LAS (7.6%), despite a 2.2% decline in Canada. Gross margin expanded by 200 basis points (bps), and Normalized EBITDA margin grew by 300 bps.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/08/40101240/meta-platforms-stock-is-rallying-thursday-whats-going-on">Meta Platforms Stock Is Rallying Thursday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy ABEV Stock</h2>
By now you're likely curious about how to participate in the market for Ambev &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stocks, like Berkshire Hathaway can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of Ambev, which is trading at $2.06 as of publishing time, $100 would buy you 48.54 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ABEV has a 52-week high of $3.13 and a 52-week low of $2.01.

Why Ambev (ABEV) Stock Is Rising Following Q2 Earnings

Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. The company reported quarterly sales of $3.847 billion which beat the analyst consensus estimate of $3.609 billion by 6.59 percent. This is a 0.76 percent increase over sales of $3.818 billion the same period last year.

Earnings Beats

Ambev Q2 2024 Adj. EPS $0.03, Inline, Sales $3.847B Beat $3.609B Estimate

UBS maintains Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) with a Buy and lowers the price target from $3.2 to $2.9.

UBS Maintains Buy on Ambev, Lowers Price Target to $2.9

Beer shares, including Anheuser-Busch Inbev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>), Ambev S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) and Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), are trading lower Monday following a weak earnings report from Heineken Holding N.V. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HKHHF#OTC">HKHHF</a>)
What Happened: Heineken its half-year results, showing revenue of €17.82 billion ($19.29 billion) and operating profit of €1.54 billion. Despite achieving organic growth in beer volume and Heineken volume, Heineken&#8217;s net profit was impacted by non-cash impairments, leading to a net loss of €48 million. The outlook for the full year has been updated, with operating profit expected to grow organically by 4% to 8%.
Upcoming Earnings:
<ul>
<li>Anheuser-Busch Inbev is set to report second-quarter earnings on August 1st before market open, with an estimated EPS of 87 cents and estimated revenue of $15.56 billion.</li>
<li>Ambev S.A. will also report second-quarter earnings on August 1st before market open, with an estimated EPS of 3 cents and estimated revenue of $3.71 billion.</li>
<li>Molson Coors Beverage Company is scheduled to report second-quarter earnings on August 6th before market open, with an estimated EPS of $1.68 and estimated revenue of $3.18 billion.</li>
</ul>
Why It Matters: The weak performance of Heineken has had a ripple effect across the beer industry. With upcoming earnings reports from other major beer companies, the market is cautious about the potential for similar disappointing results. 
Price Action:
<ul>
<li>Anheuser-Busch Inbev shares are down 2.31% at $59.96.</li>
<li>Ambev S.A. shares are flat at $2.11.</li>
<li>Molson Coors Beverage Company shares are down 2.10% at $53.19.</li>
</ul>
Photo: Engin Akyurt from Pixabay.

HKHHF

Beer Companies Shares Are trading Lower Today: What You Need To Know

Shares of beer companies are trading lower following weak earnings from Heineken.

Shares of US-listed Brazilian stocks are trading lower following Brazil's Central Bank decision.

Barclays analyst Benjamin Theurer maintains Ambev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>) with a Equal-Weight and lowers the price target from $3 to $2.5.

Barclays Maintains Equal-Weight on Ambev, Lowers Price Target to $2.5

Brazilian brewing company&nbsp;Ambev SA&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>)&nbsp;<a target="_blank" href="https://api.mziq.com/mzfilemanager/v2/d/c8182463-4b7e-408c-9d0f-42797662435e/0bdf4318-e6ab-cb8e-c44e-3aee4060421a?origin=1" rel="noreferrer noopener">reported&nbsp;</a>first-quarter&nbsp;FY24 net revenue decline of 1.2% to R$20.3 billion. On an organic basis, net revenue gained 4.5%.&nbsp;Net&nbsp;revenue&nbsp;per&nbsp;hl&nbsp;slipped&nbsp;1.4%.
Consolidated volume was virtually flat (+0.1%), as positive performances in Brazil (+6.5% in NAB and +3.6% in Beer) and Central America and the Caribbean (CAC) (+5.6%)&nbsp;were offset&nbsp;by Latin America South (-12.7%) and Canada (-7.7%).
Gross profit for the quarter dropped 1.8% to R$10.2 billion, and the margin contracted 30 basis points to 50.4%.
Normalized profit dropped 0.6% to R$3.8 billion. Normalized EBITDA climbed 1.4% to R$6.5 billion, and the normalized EBITDA margin expanded by 80 basis points to 32.2%.
Ambev held R$12.8 billion in cash and equivalents as of March-end.
&#8220;Our continued commercial momentum delivered a&nbsp;strong start to&nbsp;the year with double-digit&nbsp;Normalized
EBITDA growth (with margin expansion),&#8221; said CEO Jean Jereissati.
Price Action: ABEV shares are trading lower by 3.66% at $2.37 at&nbsp;the last check Wednesday.

Brewing Company Ambev Posts 4.5% Organic Revenue Growth In Q1

Ambev shares are trading lower after the company reported Q1 financial results.

Offerings

Press Releases

AMBEV'S 2024 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

Anheuser-Busch InBev

Compania Cervecerias Unidas, S.A. Common Stock

United Breweries Co

Boston Beer Company, Inc. (The) Common Stock

Boston Beer Co

Molson Coors Beverage Company Class B Common Stock

Molson Coors Beverage

Barclays

Jefferies

Bernstein

자본시장 투자자들은 종종 진입점, 숨은 보석, 가치 투자를 찾는다. 52주 최저 가격 또는 그 주변에서 거래되는 품질 주식은 이러한 기회를 제공한다.
최근 52주 최저가를 경신했던 기업들을 살펴보았다. 우리는 이 중 3 개 주식은 350억 달러 시가총액으로 독자들의 주목을 끌었다. 이들은 스타벅스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), 길리어드 사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) 그리고 암베브 SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>)이다.
<h2 class="wp-block-heading">스타벅스</h2>
약 86.83달러 근처에서 거래 중인 스타벅스의 주식은 바이-더-딥(Buy-the-dip) 기회를 제공하는 가능성이 있다. 시애틀에 본사를 둔 이 회사의 주식은 주식 시장에서 980억 달러가 넘는 시가총액을 차지하고 있으며, 3개월 평균 거래량은 849만 주이다.
또한 이 주식은 투자자들에게 2.63 %의 배당 수익률도 제공한다.
웰스 파고 및 TD 코웬 등은 각각 2024년 4월 1일, 2024년 4월 1일, 2024년 3월 19일에 최근 3개의 분석가 평가를 발표했다. 이러한 평가는 스타벅스 주식의 평균 목표가를 102.33달러로 제시했으며 이는 이 3명의 분석가의 평가를 기반으로 17.23 %의 잠재적 상승을 시사한다.
기사 읽기: <a href="https://www.benzinga.com/insights/news/24/03/37971829/100-invested-in-this-stock-15-years-ago-would-be-worth-1-600-today">15년 전 이 주식에 투자한 100달러, 오늘은 1600달러</a>
<h2 class="wp-block-heading">길리어드 사이언스</h2>
약 69.32달러 근처에서 거래 중인 이 바이오제약 주식은 현재 52주 최저가에 가까운 가격으로 거래되고 있다. 이 회사는 트루바다(Truvada), 아트리플라(Atripla), 데스코비(Descovy )등의 제품을 포함한 HIV/AIDS 치료용 항레트로바이럴 약물 개발으로 폭넓은 인정을 받았다.
길리어드 주식의 배당 수익률은 4.43%로 강하다.
웰스 파고, 미즈호, 트루이스트 증권은 최근 발표된 3개의 분석가 평가를 제공했다. 이러한 평가는 길리어드 주식의 평균 주가 목표가를 83.33달러로 제시한다.
이러한 평가를 기반으로, 이 회사의 가격에서는 약 20.16%의 상승 잠재력이 나타난다.
<h2 class="wp-block-heading">암베브</h2>
암베브 SA(Ambev SA)는 스콜(Skol), 브라흐마(Brahma), 안타르크티카(Antarctica), 버드와이저(Budweiser) 등 인기 맥주 브랜드의 포트폴리오로 널리 알려져 있다. 2.36달러의 52주 최저가에 근접한 2.40달러에 거래 중인 암베브 주식은 매력적인 배당 수익률 6.26%를 제공한다.
8개의 최신 분석가 평가를 기반으로, 암베브의 평균 주가 목표가는 2.2달러다. 가장 최근의 평가는 바클레이즈, 제프리스 및 번스타인의 것으로 각각 2024년 3월 4일, 2023년 11월 22일, 2023년 5월 24일에 발행됐다.
이러한 평가들은 암베브 주식의 평균 주가 목표가를 3.2달러로 나타내고 있다. 따라서 이번 분석가 평가를 기반으로 회사의 주가에는 약 32.51 %의 상승 잠재력이 있다는 것을 시사한다.
이 조사 결과 이러한 품질의 주식들이 투자자들에게 다가올 수 있는 달에 잠재적인 상승을 제공할 수 있다는 가능성을 시사한다.
다음 기사: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38032100/redditors-identify-best-undervalued-stocks-for-2024">2024년 선정된 &#8216;가장 가치 있는 저평가 주식&#8217;을 레딧 사용자가 발표</a>

Comments

Ambev

뉴스

에 대한 최신 뉴스 Ambev (NYSE:ABEV) 주식

화요일, 4월 09, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌